
Opinion|Videos|June 2, 2025
Early Detection of ccRCC
Panelists discuss how deep learning applied to imaging data sets may advance kidney cancer assessment, though they believe the next major leap will require true molecular imaging that reveals what tumors are expressing.
Advertisement
Episodes in this series

Future Directions for Imaging in Kidney Cancer
Main Discussion Topics:
- Potential for deep learning and artificial intelligence (AI) to extract additional information from imaging data sets
- Recognition that computational approaches have limitations
- The future likely requires molecular imaging that assesses tumor expression patterns.
Key Points for Physicians:
- AI and deep learning may identify imaging features not apparent to human readers.
- Computational approaches alone may have limitations.
- Molecular imaging represents the next frontier in renal mass characterization.
Notable Insights:
Although AI approaches show promise, the experts believe the most significant advances will come from molecular imaging techniques that directly assess tumor biology.
Clinical Significance:
Combination of computational approaches and molecular imaging will likely provide the next major advance in renal mass characterization.
Advertisement
Related to this article

Eugene Cone, MD, discusses recombinant BCG for NMIBC, including ongoing clinical evaluation and its potential to address ongoing BCG supply challenges.

A national study found that use of MRI before prostate biopsy increased in US hospitals from 2017 through the first half of 2026.

The assay is designed to enable faster pathogen identification and susceptibility testing to guide UTI management.

The UroOnc Minute: Neoadjuvant Therapy Before Radical Prostatectomy, With Isaac Y. Kim, MD, PhD, MBA
Isaac Y. Kim, MD, PhD, MBA, joins to discuss the evolving data surrounding neoadjuvant therapy before radical prostatectomy in prostate cancer.

The safety and efficacy of vibegron are supported by data from the phase 3 COURAGE and EMPOWUR trials.

Marian Cuello joins to discuss sexual wellness and the importance of normalizing conversations about sexual health for all individuals.
Advertisement
Advertisement
Trending on Urology Times
1
Evidence for Combining Prostatic Urethral Lift With Radiotherapy
2
FDA grants breakthrough device designation to urine ID/AST panel
3
The UroOnc Minute: Neoadjuvant Therapy Before Radical Prostatectomy, With Isaac Y. Kim, MD, PhD, MBA
4
Use of prebiopsy prostate MRI increasing across US hospitals, study finds
5

